These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25406300)

  • 1. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
    Schutt RC; Trachtenberg BH; Cooke JP; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Bhatnagar A; Johnstone BH; Lai D; Resende M; Ebert RF; Wu JC; Sayre SL; Orozco A; Zierold C; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Circ Res; 2015 Jan; 116(1):99-107. PubMed ID: 25406300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD
    Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Bhatnagar A; Bolli R; Johnstone BH; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Yang PC; Cooke JP; Schutt RC; Trachtenberg BH; Orozco A; Resende M; Ebert RF; Sayre SL; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Am Heart J; 2016 Sep; 179():142-50. PubMed ID: 27595689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
    Seitz A; Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; May AE; Empen K; Chorianopoulos E; Ritter B; Pirr J; Arseniev L; Heuft HG; Ganser A; Abu-Zaid E; Katus HA; Felix SB; Gawaz MP; Schultheiss HP; Ladage D; Bauersachs J; Mahrholdt H; Greulich S
    Clin Res Cardiol; 2020 May; 109(5):539-548. PubMed ID: 31401672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.
    Hu X; Huang X; Yang Q; Wang L; Sun J; Zhan H; Lin J; Pu Z; Jiang J; Sun Y; Xiang M; Liu X; Xie X; Yu X; Chen Z; Tse HF; Zhang J; Wang J
    Int J Cardiol; 2015 Apr; 184():446-451. PubMed ID: 25755063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
    Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
    Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; Bonarjee V; Larsen AI; May AE; Empen K; Chorianopoulos E; Tebbe U; Waltenberger J; Mahrholdt H; Ritter B; Pirr J; Fischer D; Korf-Klingebiel M; Arseniev L; Heuft HG; Brinchmann JE; Messinger D; Hertenstein B; Ganser A; Katus HA; Felix SB; Gawaz MP; Dickstein K; Schultheiss HP; Ladage D; Greulich S; Bauersachs J
    Eur Heart J; 2017 Oct; 38(39):2936-2943. PubMed ID: 28431003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.
    Luu B; Leistner DM; Herrmann E; Seeger FH; Honold J; Fichtlscherer S; Zeiher AM; Assmus B
    Circ Res; 2017 Jun; 120(12):1938-1946. PubMed ID: 28351842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
    Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
    Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
    Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
    Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.